GSK3B and prostate cancer: In this study we use breast cancer cells with low levels of endogenous activated GSK-3 and β-catenin and prostate cancer cells with constitutively activated GSK-3 and β-catenin to show that, GSK3β regulates cadherin-11 expression in two ways.